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ABSTRACT
PURPOSE: To analyze the effects of simvastatin (SVT) in the locomotion, anxiety and memory of rats, as a reflection of the 
administration of a minimum dose capable of stimulating bone regeneration in defects in the calvariae.  
METHODS: Surgical procedures were performed in 15 female Wistar rats, 2-month old, to insert the grafting material regenerator 
(Bone-ceramic®) and/or SVT, followed by behavioural and cognitive assessments in the 7th, 30th and 60th days post surgery. 
RESULTS: The SVT locally applied with the goal of bone regeneration in defects created in rat calvariae does not interfere with 
locomotion, anxiety levels and/or memories of rats, except for the first week following surgery, when an anxiolytic effect was observed, 
as a result of a possible central action. 
CONCLUSION: Failure to provoke any response within 30 and 60 days post surgical procedures suggests that SVT may constitute a 
good choice in stimulating bone regeneration without affecting the long term neural functions.
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Introduction
For many years the gold standard applied to bone 
grafting has been of the autogenous type. The bone graft is 
obtained from the same patient from different intra- or extra-oral 
donor regions, such as parts of the mandible, skullcap or tibia1. 
The search for a bone substitute has increased over the years due 
to the limited volume of bone removed from the donor area and 
mainly because of surgical morbidity2. The search for a material 
that eliminates the need to intervene in the donor area could lead 
to further advances in biomaterials research and the production 
of different bone substitutes.
There are some factors that are valuable in bone 
regeneration, e.g., hormones, cytokines and growth factors, such as 
bone morphogenetic protein3, drugs such as calcitonin4 and statins5. 
The latter, in turn, are widely used to lower blood cholesterol level 
and can stimulate bone formation, as observed by the increasing 
activity of the alkaline phosphatase, osteocalcin expression levels 
and mineral deposits, suggesting an anabolic effect on bone tissue 
by increasing osteoblast differentiation6. Some studies suggest 
that simvastatin (SVT) enhances differentiation of osteoblasts in 
humans, measured by increased alkaline phosphatase activity and 
the expression of osteoblast-related genes7.
Although there is a great deal of information indicating 
the beneficial effect of SVT in bone regeneration, results 
of preclinical and clinical studies have shown conflicting 
results with its use. Studies indicate that the effects of SVT 
may be influenced by factors such as method and route of 
administration and duration of exposure. In addition, there 
are also many questions about the optimal concentration and 
the best carrier for the drug. The materials available for bone 
regeneration are still expensive and unaffordable to many 
patients, and therefore, there is a tireless search by the scientific 
community for a biomaterial that is efficient and, at the same 
time, accessible to the majority of the population6,8.
Attention should also be given to the fact that the 
SVT influence another aspect that cannot be ruled out in this 
present context, which concerns to their interference on aspects 
of neurobehaviour. In recent years, attention has been given 
to this statin in the treatment of anxiety and depression9,10, for 
its therapeutic potential in the treatment of neurodegenerative 
diseases involving excitotoxicity11, and loss of learning and 
memory12. Nevertheless, to the best of our knowledge, no work 
in the literature has investigated whether a low dose of SVT, able 
to promote bone healing, may interfere with the cognitive and 
behavioural aspects of the users. 
In order to investigate this, the aim of this study was 
to assess the behavioural and cognitive effects of the SVT dose 
seeking to stimulate bone regeneration in defects created in the 
calvariae of rats.  
Methods 
Research approved by the Ethics Committee on Animal 
Use, Faculty of Medicine, University of Brasília (protocol UnB 
doc 44299-2012).
Fifteen female 2-month old Wistar rats were used at the 
beginning of the experiments, each weighing 300 g, originating 
from the Animal Facilities of the Faculty Sena Aires (Valparaiso 
de Goias, GO, Brazil). The animals were housed in groups of five 
per cage, kept under standard conditions with food and water ad 
libitum, room temperature, light/dark cycle of 12 hours (06:00 
to 18:00 h), After the surgical procedures and the behavioural 
assessments, the animals were sacrificed by decapitation eight 
weeks after the onset of the experiments, which is the time required 
for bone healing in rats. The brains were dissected and stored in 
10% formalin for further studies.
Preparation of simvastatin
The ideal amount of BoneCeramic® (BC) and SVT 
solution to fill a bone defect 5 mm in diameter was standardized, 
using a condensation silicone template created to mimic the 
bone defect. We determined that collagen sponge (CS) or 15 
mg of BC and 15μL of a SVT (BC+SVT) solution in ethanol 
were sufficient to fill the designed defect. The SVT solution 
(Farmogral®, Brasilia, Brazil) was prepared to contain 0.1 mg of 
SVT in 15μL of SOLUTION23. 
Anaesthesia and surgery procedures
The rats were anesthetized with ketamine (80 mg/kg) and 
xylazine (10 mg/kg) by intramuscular route before the induction of 
bilateral defects in the calvariae. The rat’s skulls were desinfected 
with povidone-iodine solution, a linear incision was made on the 
region, and a full thickness flap elevated exposing the bone. A 5mm 
diameter trephine Neodente® drill (Curitiba, PR, Brazil) was used 
to create a bone defect on both sides of the calvariae, totalling two 
bone defects on each rat. Constant irrigation with a saline solution 
was used in order to avoid overheating the bone. The defects were 
filled with different materials as described below. At the end of 
the surgical procedures, a suture was made using a mononylon 
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5.0Etchon® thread, as demonstrated in Figure 1. During surgery 
procedures special care was taken not to damage the duramater. 
All surgical instruments had been sterilized in an autoclave. For 
pain management after surgery recovery and on the next day, 150 
mg/kg of acetylsalicylic acid was administered, by the gavage 
route every four hours.
Open field test: The animals were individually placed in 
the centre of a wooden arena (60 x 60 x 35 cm3) divided into nine 
quadrants, to evaluate the number of sections crossed by the animal 
during 5 min. Immediately after the animal was placed in the centre of 
the arena, its movements began to be scored. Locomotor activity was 
considered only when the animal placed all four paws onto one square.
Elevated plus maze test: This apparatus was used on 
the basis of its documented validity to detect both anxiolytic- and 
anxiogenic-like drug effects in rats13. Made of wood and covered 
with impermeable Formica, it was placed 50 cm above the floor. The 
four arms were 50 cm long and 10 cm wide. Two opposite arms were 
surrounded by walls (40 cm high, enclosed arms), while the other 
two were devoid of enclosing walls (open arms) surrounded by a 1 
cm high Plexiglas edge. The four arms were connected by a central 
platform (10 x 10 cm2). Each rat was placed in the centre of the maze 
facing an enclosed arm. The animals were observed for a 5-min test 
period and the anxiogenic-like effects were defined as a decrease in 
the proportion of open arm entries divided by the total number of arm 
entries, and a decrease in the time spent on open arms relative to the 
total time spent on both arms. Whenever a rat placed all four paws 
onto one arm, one entry was recorded. The total number of enclosed 
arm entries was also used as a measure of locomotor activity.
Inhibitory avoidance task: The equipment was an acrylic 
box (50 cm x 25 cm x 25 cm), the floor of which consisted of parallel 
stainless steel bars (1 mm diameter) spaced 1 cm apart. A platform (7-
cm wide x 2.5-cm high) was placed on the floor against the left wall. 
The animals were placed on the platform, and the time from latency to 
step-down on the grid with four paws was measured with an automatic 
device. The experimental subjects were submitted to the inhibitory 
avoidance task using a protocol similar to that previously described14. 
During training sessions, immediately after stepping down on the 
FIGURE 1 – Illustrations of the sequence of surgical procedures for the 
induction of bilateral defects in the calvariae of rats. A) Demarcation of 
the area where the bone defect is to be performed; B) Removal of the bone 
layer that characterizes the bone defect; C) Administration of a substance 
corresponding  to what was chosen for each investigated group, D) area 
procedure finalized and ready to be sutured.
Experimental design
The animals were behaviourally assessed on the 7th, 30th 
and 60th days after surgical procedures in order to verify the level 
of stress/anxiety and any cognition impairment. For the purposes 
of the experiments and control, the animals were divided into three 
groups of five animals each:
Group 1 (G1): In this control group the bone defects was 
made on the left side to receive no treatment, being filled only with 
the blot clot. On the right side the bone defects received different 
types of fillers: BC, BC+SVT, CS, or CS+SVT.
Group 2 (G2): (100% synthetic bone substitute, 
osteoconductive, made up of biphasic calcium phosphate particles) 
– on the left side the bone defects received treatment only with 
BC, while the right side received BC+SVT.
Group 3 (G3): On the left side the bone defects received 
CS, and on the right side the animals received CS+ SVT.
Behavioural tests
Animals were acclimated to the experimental room for 
at least 1 h before beginning the experimental procedures, which 
were carried out between 8 a.m. and 12 p.m. in order to avoid 
circadian influence and or any kind of noise or interference from 
external factors in the experimental environment. The behavioural 
tests were conducted with each separate group of animals (n=5 
animals in each group), as demonstrated in Figure 2. 
FIGURE 2 - Schematic representation of the steps of the experimental 
procedures adopted in the research. A) The surgeries took place on day 1 of 
the beginning of the experiments, and behavioural evaluations occurred on 
the 7th, 30th and 60th days after anaesthesia and surgery procedures in order 
to verify the level of stress/anxiety and some cognition impairment; B) The 
tests used in the research were open field (locomotion); elevated plus-maze 
(anxiety); and “step down” inhibitory avoidance (memory) tests.
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grid, the animals received a 0.4-mA, 1.0-s scrambled foot shock. 
During test sessions, no foot shock was administered, and the step-
down latency (maximum 180 sec) was used as measure of memory 
retention. Animals were submitted to a single training session. In 
order to evaluate short-(STM) and long-term (LTM) memories, test 
sessions were performed 1h and 24h after training, respectively.
Statistical analysis
The results were expressed as the mean ± SEM (standard 
error of the mean) of 15 animals (five animals/group). Data 
were analyzed using a GraphPad Prism v5 statistical program. 
Locomotion and anxiety-related behaviour were analyzed using 
the one way Analysis of variance (ANOVA) followed post hoc by 
the Newman-Keuls test. Data on the inhibitory avoidance task are 
shown as the medians (interquartile range) of step-down latencies. 
Comparisons of the step-down test session latencies among groups 
were performed with using the Kruskal–Wallis test followed by 
Dunn’s multiple comparison test. Statistical significance was 
considered when p≤0.05.
Results
The evaluation of SVT administration in the calvariae of 
rats for locomotor activity on the 7th, 30th and 60th post-surgical 
days is demonstrated in Figure 3. Statistical analysis performed 
by the one-way ANOVA did not detect any statistical difference 
among the groups and/or in the recovery time of the animals 
[F(2,14)=2.022, p=0.1750].
To evaluate the anxiety levels, the animals were tested in 
the EPM (Figure 4), which the percentage of entries into the open 
arms of the maze and the time spent in these arms were considered. 
The one-way ANOVA followed by a post hoc Newman Keuls test 
detected an increase in the percentage of open arm time of the 
EPM on the 7th day post surgery [F(2,14)= 8.209, p=0.0057], but not 
in any other of the assessments. This behaviour response seemed 
to be specific to an anxiolytic effect of SVT expected early after 
treatment, although the frequency of enclosed arms entries of the 
EPM [F(2,14)= 0.5566, p= 0.5873] was not affected.
FIGURE 3 – Effects of simvastatin (0.1 mg/kg) on locomotor activity of 
rats evaluated in the open field test for 5 min, on the 7th, 30th and 60th days 
post surgery. The results are expressed as mean ± SEM of five animals per 
group. G1= control group; G2= left side: BoneCeramic® (BC)/right side: 
BoneCeramic® + simvastatin (BC+SVT); G3= left side: Collagen sponge 


















FIGURE 4 – Effects of simvastatin (0.1 mg/kg) on the anxiety-like 
behaviour of rats evaluated in the elevated plus maze test on the 7th, 30th 
and 60th days post surgery. The results are expressed as mean ± SEM of five 
animals per group. *p≤0.05 compared to the control group (G1) on the 7th 
day post surgery (One way ANOVA; Newman-Keuls test). G1= control 
group; G2= left side: BoneCeramic® (BC)/ right side: BoneCeramic® + 
simvastatin (BC+SVT); G3= left side: Collagen sponge (CS)/ right side: 
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The STM and LTM were investigated in the step down 
inhibitory avoidance test, by which the animals had to recognize 
the aversive stimulus when they were evaluated 1 hour (STM) or 
24 hours (LTM) after training on the 7th day post surgery, and then 
again on the 30th and 60th days (Figure 5). The animals recognized 
the stimulus and increased their latency time on the platform of 
the apparatus, for STM on the 7th day [11.62, p=0.02] and the 30th 
day [13.02, p=0.01]. LTM also made a difference compared to 
the control group on the 60th day [11.41, p=0.02]. No statistical 
difference was observed between STM and LTM or LTM over 
time in each group.
It is well known that the natural behaviour of rodents 
(rats and mice) can be measured by the number of enclosed arm 
entries into a maze and by locomotor activity in an open field test. 
Researchers have noted that rodents are motivated to investigate 
new objects and places, but the novelty also induces fear, which may 
tend to suppress exploration or encourage them to flee from the new 
situation15. Drugs (or other manipulations) that reduce the presumed 
inhibitory mechanism can increase the levels of exploitation, without 
affecting the responses to novelty16. The results obtained in the 
present study showed that SVT did not interfere with locomotion, 
since the locomotion of the animals remained independent of the 
treatment and the period of time investigated
Regarding anxiety, this  behaviour, very common in 
everyday life, is also present in the dentist’s chair, independent of 
the clinical manifestations presented by patients. There is a good 
reason to believe that the same neural systems are involved in the 
generation of the phenomena of acute physiological states of fear 
and anxiety, even though the situations and conditions that lead 
to physiological and pathological anxiety are different17. Anxiety 
disorders that are more directly related to phobic situations or 
originating from phobic stimuli are classified as exogenous anxiety. 
Furthermore, there are multiple types of anxiety disorders, each one 
with a characteristic pattern of response.  Major advances have been 
made towards understanding the neurobiology of fear responses18.
Several studies have suggested the influence of SVT as 
a probable therapy for treating anxiety and other changes related 
to this disorder9,10,19. Based on this information, our interest was to 
know how far a low dose intended for use in bone regeneration could 
also interfere with behaviour. It was observed on the 7th day post 
surgery that the animals showed a significant anxiolytic response, 
depending on the osteoconductive material used. An adaptation 
of the response to the latter was demonstrated, whereas no similar 
behaviour or other kind of behaviour alteration was observed during 
the recovery of the animals in the process of bone regeneration.
With respect to the correlation between locomotor activity 
and anxiety-related behaviour, our results were the opposite of 
those produced by the previous reports on  SVT hyperactivity in 
the animals; this was a reflection of the high amount of exploration 
time of the animals in the open arm of EPM, suggestive of 
anxiolytic effect19. Locomotion of the animals used in our research 
did not alter during the tests. These conflicting results may be are 
due to the dose used. Authors used a very high dose of 10 mg/kg/
day, whereas in our studies the dosage was 0.1 mg/kg, which was 
enough to produce bone regeneration (data not shown) without 
significant interference in behaviours investigated after the first 
week of surgical recovery.
FIGURE 5 - Effects of simvastatin (0.1 mg/kg) on short- and long-term 
memories of rats evaluated in the “step-down” inhibitory avoidance test on 
the 7th, 30th and 60th days post surgery. The results are expressed as mean 
± SEM of 5 animals per group. STM was evaluated 1h after the training. 
LTM was evaluated 24h after STM on the 7th day post surgery, and again 
on the 30th and 60th days. *p≤0.05 compared to the control group (G1) on 
7th day post surgery (Kruskal-Wallis test, followed by Dunn’s multiple 
comparison). G1= control group; G2= left side: BoneCeramic® (BC)/ right 
side: BoneCeramic® + simvastatin (BC+SVT); G3= left side: Collagen 
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In a general context, the results showed that the SVT dose-
seeking bone regeneration in defects created in rat calvariae, does 
not interfere with behavioural and/or cognitive responses, except 
after the first week after application, which showed an anxiolytic 
effect, reflecting a possible action arising from the first specific 
effects of the SVT on the central nervous system. On the other 
hand, the lack of response on the 30th and 60th days corresponding 
to the period of surgical recovery suggests that SVT may be a good 
choice in stimulating bone regeneration without affecting long-
term locomotion, anxiety levels and aspects of memory.
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Attention is drawn here to the fact that in the first week 
of surgery recovery, the animals showed anxiolytic effect that 
was osteoconductive- dependent. There are no reports in the 
literature emphasizing the anxiolytic property of BoneCeramic® 
and any mechanism by which it might induce such behaviour. 
However, it is well known that pre-clinical studies have shown 
that the major receptor involved in the observed responses is 
the N-methyl-D-aspartate (NMDA) receptor. In some of the 
research previously reported, SVT behaved as an antagonist of 
these receptors19. Considering this hypothesis, it is possible to 
justify the fact that the anxiolytic response observed in animals 
undergoing surgical procedures may perhaps have involved the 
NMDA receptors.
In addition, emphasis also has been given to the fact that 
statins have shown neuroprotective effects in some neurological 
diseases. In a comparative study on the effect of commercially 
available statins on the neural damage and memory impairment 
in mice produced by Kainate, which is a glutamate agonist, SVT 
was more effective in reducing the harmful effects, including the 
severity of seizures, excitotoxicity, oxidative damage, neuritic 
and apoptosis dystrophy11. With the SVT dose used in the present 
experiment, the animals showed no significant changing in STM 
and LTM, regardless of the time of bone regeneration.
The mechanism by which SVT promotes bone 
regeneration has long been investigated, showing that the influence 
of lipid-lowering therapies generates many positive results. On 
the other hand, there are many contradictory results with regard 
to the role of cholesterol in cognitive functions. However, it 
is clear that the conflicting data are mainly due to changes in 
dosage and duration of treatment in subjects investigated. For 
example, the effect of local application of SVT on bone growth is 
more favourable with lower doses (2.2 mg to 0.5 mg), reducing 
inflammation to clinically acceptable levels8. The optimal dose 
to stimulate maximum bone regeneration without inducing 
inflammation in rat calvariae is 0.1 mg, especially if associated 
with an osteoconductive biomaterial able to release the drug 
gradually20.  Our results support this information. SVT in a dose 
of 0.1 mg is effective in regenerating bone in rat calvariae with 
no considerable effect at central nervous system. 
In overall, the results here obtained with the SVT dose 
administered locally in rat calvariae may constitute an alternative 
to bone regeneration without substantial central interference over 
time. Furthermore, attention should be given to the fact that local 
osteogenesis helps to accelerate bone regeneration making SVT a 
valuable investment for the pharmaceutical industry in search of 
the advances in this regard.
Conclusion
Failure to provoke any response within 30 and 60 days 
post surgical procedures suggests that SVT may constitute a good 
choice in stimulating bone regeneration without affecting the long 
term neural functions
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